Kiora Pharmaceuticals to Present at Oppenheimer's 36th Annual Healthcare Life Sciences Conference

Kiora Pharmaceuticals (NASDAQ: KPRX) will present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference on Thursday, February 26, 2026 at 3:20 p.m. ET.

Rhea-AI Summary

Kiora Pharmaceuticals (NASDAQ: KPRX) will present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference on Thursday, February 26, 2026 at 3:20 p.m. ET.

A live webcast will be available on the company's investor relations website ir.kiorapharma.com, with a replay accessible for approximately 90 days.

Argus Feb 19 session

-1.44% close to close Open Argus

Details

News Market Reaction – KPRX

In the Feb 19 session, KPRX declined 1.44%, reflecting a mild negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

Market Context

This announcement signals continued investor-relations activity, with Kiora presenting at a major he...

Analysis

This announcement signals continued investor-relations activity, with Kiora presenting at a major healthcare conference on February 26, 2026 and offering a webcast replay for 90 days. In context of recent updates on Phase 2 retinal trials, patents, and collaboration initiatives, the event gives management another platform to discuss strategy and progress. Investors may watch for any new qualitative commentary on development timelines, partnering discussions, or cash runway beyond late 2027 in the accompanying presentation materials.

Key Figures

Conference edition: 36th Annual Presentation date: February 26, 2026 Presentation time: 3:20 p.m. ET +1 more

Conference edition

36th Annual

Oppenheimer Healthcare Life Sciences Conference

Presentation date

February 26, 2026

Scheduled conference presentation date

Presentation time

3:20 p.m. ET

Scheduled time for Kiora’s presentation

Webcast replay window

90 days

Duration replay will be available on IR website

Historical Context

5 past events · Latest: Jan 27

5 events

1. Jan 27

   Advisory board addition

   24h Move

   -0.5%

   Retinal specialist joined Scientific Advisory Board to guide retinal strategy.

2. Dec 01

   Patent and trial update

   24h Move

   -2.5%

   New U.S. patent on KIO-100 formulations and active Phase 2 KLARITY trial.

3. Nov 07

   Earnings and pipeline

   24h Move

   +0.4%

   Q3 2025 results, cash position, and progress in two Phase 2 retinal trials.

4. Oct 30

   Consortium collaboration

   24h Move

   +0.8%

   Joined RARE-X Vision Consortium to support rare ocular disorder research.

5. Oct 15

   Conference participation

   24h Move

   -0.7%

   Participation in ophthalmology-focused investor and industry events.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Encinitas, California--(Newsfile Corp. - February 19, 2026) - Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) today announced that the company will present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference on Thursday, February 26, 2026, at 3:20 p.m. ET.

A live webcast will be available on Kiora's investor relations website, ir.kiorapharma.com, on the IR homepage and under the News & Events section. A replay of the webcast will be available for approximately 90 days.

About Kiora Pharmaceuticals
Kiora Pharmaceuticals is a clinical-stage biotechnology company developing advanced therapies for retinal disease. We target critical pathways underlying retinal diseases using innovative small molecules to slow, stop, or restore vision loss. KIO-104 is being developed for the treatment of retinal inflammation. It is a next-generation, non-steroidal, immuno-modulatory, and small-molecule inhibitor of dihydroorotate dehydrogenase (DHODH). KIO-301 is being developed for the treatment of retinitis pigmentosa, choroideremia, and Stargardt disease. It is a molecular photoswitch that has the potential to restore vision in patients with inherited and/or age-related retinal degeneration.

In addition to news releases and SEC filings, we expect to post information on our website, www.kiorapharma.com, and social media accounts that could be relevant to investors. We encourage investors to follow us on X and LinkedIn as well as to visit our website and/or subscribe to email alerts.

Contacts:
Investors
investors@kiorapharma.com

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/284505

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will Kiora Pharmaceuticals (KPRX) present at Oppenheimer's 36th Annual Healthcare Life Sciences Conference?

Kiora will present on Thursday, February 26, 2026 at 3:20 p.m. ET. According to the company, the presentation is part of the conference program and will be available via live webcast on the investor relations site.

How can investors watch Kiora Pharmaceuticals (KPRX) presentation on February 26, 2026?

Investors can watch via a live webcast on ir.kiorapharma.com. According to the company, the webcast is accessible from the IR homepage under News & Events and will stream live at the scheduled time.

Will there be a replay of Kiora Pharmaceuticals (KPRX) Oppenheimer conference presentation and for how long?

Yes, a replay will be available for approximately 90 days after the live event. According to the company, the replay will be posted on the investor relations site for on‑demand viewing during that period.

What time is Kiora Pharmaceuticals (KPRX) scheduled to present at the Oppenheimer conference in ET?

Kiora is scheduled to present at 3:20 p.m. ET on February 26, 2026. According to the company, attendees and investors can join the live webcast at that exact time via the IR website.

Where on Kiora Pharmaceuticals' website will the Oppenheimer conference webcast be posted?

The webcast will be posted on the company's investor relations site at ir.kiorapharma.com. According to the company, it will appear on the IR homepage and under the News & Events section for live and replay access.